Huron Consulting Group (NASDAQ: HURN), a leading provider of business consulting services, today announced a strategic alliance with Forte Research Systems, a leading provider of enterprise research software, to enhance joint offerings to research institutions.
Huron Consulting Group (NASDAQ: HURN), a leading provider of business consulting services, today announced a strategic alliance with Forte Research Systems, a leading provider of enterprise research software, to enhance joint offerings to research institutions. The Huron-Forte alliance is the result of a shared commitment to offer impactful consulting services and effective software solutions to the research industry to provide clients the following:
“The Huron-Forte alliance allows both organizations to provide greater value to our shared clients,” said Rick Rohrbach, managing director, Huron Consulting Group. “Huron can help clients transform their clinical research business processes using Forte’s OnCore. Huron will help Forte customers optimize the implementation of OnCore and other Forte software solutions to improve their return on investment. Most importantly, the interfaces between our systems will provide customers a seamless and effective research administration solution.”
“The Huron-Forte relationship will help clients gain greater efficiency with their clinical trials portfolio. With increasing enterprise-wide implementations and adoption of OnCore, Huron brings the required experience in operational and implementation planning to serve a growing need,” said Srini Kalluri, president and chief executive officer, Forte Research Systems. “Existing and new OnCore clients will also be able to take advantage of a planned standards-based interface between Huron’s Click IRB and OnCore application, which will further enhance researcher productivity. Through this alliance, we are building on past success in working closely together to broadly address customer needs. The people and approaches on both sides are aligned well for taking this important step together.”
The Huron-Forte alliance aims to increase researcher productivity and improve compliance oversight through tight integration of the two companies’ products and services. Huron will expand its ability to provide clinical trials solutions beyond its current highly configurable Click Portal. At the same time, Forte gains a deployment partner with significant industry expertise and scale to accelerate the market adoption of their leading OnCore product, which includes CTMS, electronic data capture, and biospecimen management functionality.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.